Condition

Pediatric Solid Tumor clinical trials and research

• 7Clinical trials
• 2Countries

Newest Pediatric Solid Tumor clinical trials

All recruiting trials (7)

• B7-H3 CAR T cells for relapsed or refractory solid tumors in children and young adults

  This study tests a new B7-H3 CAR T cell therapy to see if it is safe and can help kids and young adults whose solid tumors have come back or stopped responding to standard treatments.

  Recruiting Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07358260

• Using irinotecan to treat children with relapsed solid tumors based on their UGT1A1 gene

  This study is testing if a combination of irinotecan, temozolomide, and vincristine can help children with relapsed solid tumors who have a specific gene type feel better and live longer.

  Recruiting Phase 1 Sun Yat-sen University · Guangzhou, Guangdong · NCT06760117

• Using a diabetes medication to treat pediatric brain and solid tumors

  This study is testing if a diabetes medication can be safely used with regular treatments to help children with hard-to-treat brain and solid tumors.

  Recruiting Phase 1 Washington University School of Medicine · St Louis, Missouri · NCT05521984

• Combining cyclophosphamide, sorafenib, bevacizumab, and atezolizumab for children and young adults with relapsed solid tumors

  This will test whether giving atezolizumab and bevacizumab every three weeks together with daily cyclophosphamide and dose‑adjusted sorafenib is safe and can shrink relapsed or hard‑to‑treat solid tumors in children and young adults, including fibrolamellar carcinoma.

  Recruiting Phase 1/2 St. Jude Children's Research Hospital · Germantown, Tennessee and 1 other locations · NCT05468359

• B7-H3 CAR T-cell therapy for pediatric solid tumors

  This study is testing a new type of immune therapy using specially modified T cells to see if it can help children with tough-to-treat solid tumors.

  Recruiting Phase 1 St. Jude Children's Research Hospital · Memphis, Tennessee · NCT04897321

• New drug metarrestin for treating metastatic solid tumors

  This study is testing a new drug called metarrestin to see if it can safely shrink tumors in adults and teens with advanced solid tumors that haven't responded to other treatments.

  Recruiting at 2 sites Phase 1 National Institutes of Health Clinical Center (CC) · Fairway, Kansas and 1 other locations · NCT04222413

• Understanding rare solid tumors and their genetic factors

  This study is looking to learn more about rare solid tumors and their genetic factors by collecting samples and medical histories from people who have these tumors to help improve future treatments and prevention.

  Recruiting at 3 sites National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 2 other locations · NCT03739827

Related topics

Quick answers

How many Pediatric Solid Tumor clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (6 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 5, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →